![Marlyn Mathew](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marlyn Mathew
Director of Finance/CFO at
ZURA BIO LIMITED
Net worth: 715 668 $ as of 2026-08-30
Profile
Marlyn Mathew is currently Chief Financial & Accounting Officer at Zura Bio Ltd., starting in 2026.
Formerly, Ms. Mathew was Controller at Immunovant, Inc. from 2019 to 2022.
Education includes undergraduate studies at Rutgers State University of New Jersey.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-16 | 129,182 ( 0.13% ) | 715 668 $ | 2026-08-30 |
Marlyn Mathew active positions
| Companies | Position | Start |
|---|---|---|
| ZURA BIO LIMITED | Director of Finance/CFO | 2026-04-19 |
Former positions of Marlyn Mathew
| Companies | Position | End |
|---|---|---|
| IMMUNOVANT, INC. | Comptroller/Controller/Auditor | 2022-04-30 |
Training of Marlyn Mathew
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
55
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Zura Bio Ltd.
 Zura Bio Ltd. BiotechnologyHealth Technology Operates as a multi-asset clinical-stage biotechnology company that focuses on develops novel medicines for immune and inflammatory disorders | Health Technology |
- Stock Market
- Insiders
- Marlyn Mathew
